New molecular markers for the study of tumour lymphangiogenesis

Anticancer Research

Volumn 21, Issue 6 B, 2001, Pages 4279-4283

  Jackson, David G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Hyaluronan; Lymphangiogenesis; Lymphatic; LYVE 1; Tumour; VEGF C; VEGFK 3

Indexed keywords

MOLECULAR MARKER; PODOPLANIN; PROTEIN LYVE 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; CANCER; CANCER CELL; ENDOTHELIUM CELL; HUMAN; IMMUNOHISTOLOGY; LYMPH FLOW; LYMPH NODE; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035574121     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
2. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
3. Expression of hyaluronan in benign and malignant breast lesions
4. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
5. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis
6. Podoplanin, novel 43kD membrane protein of glomerular epithelial cells, is down-regulated inpuromycinnephrosis
7. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium
8. Lack of lymphangiogenesis in human primary cutaneous melanoma
9. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
10. Microvessel count predicts survival in uveal melanoma
11. Uptake and degradation of hyaluronan in lymphatic tissue
12. Turnover and metabolism of hyaluronan
13. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
14. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
15. Enzyme-histochemical study on postnatal development of rat stomach lymphatic vessels
16. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to endothelium of lymphatic vessels during development
17. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
18. Hyaluronan
19. Lymphatic endothelium isolation, characterization and long-term culture
20. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
21. Critical review of the sentinel node hypothesis
22. Microvessels that predict axillary lymph node metastases in patients with breast cancer
23. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
24. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
25. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nrn23 expression associated witll microdissemination in the lymph nodes in stage I non-small cell lung cancer
26. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
27. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing
28. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines
29. Lack of lymphatics specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumours
30. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium
31. Lymphatics of the skin. Neglected but important
32. Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors
33. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagn with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and haemangioma in situ
34. Identification of lymphatic vessels by using a monoclonal antibody specific for the human thoracic duct
35. Vascular endothelial growth factor-D promotes tumour growth and spread via the lymphatics
36. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
37. Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes
38. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
39. VEGFs, receptors and angiogenesis
40. The histochemical distribution of 5-nucleotidase and unspecific alkaline phosphatase in the testicle of various species and in two human seminomas
41. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells
42. Prox-1 function is required for the development of the murine lymphatic system
43. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity
44. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer